Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
ClinicalTrials.gov study NCT00687323. IPD Sharing: YES. Countries: 0. Publications: 1.
Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00909168. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
ClinicalTrials.gov study NCT04666649. IPD Sharing: NO. Countries: 1. Publications: 47.
Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2
ClinicalTrials.gov study NCT00931138. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients
ClinicalTrials.gov study NCT02863302. IPD Sharing: NO. Countries: 1. Publications: 2.
Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) </= 60y. After First CR
ClinicalTrials.gov study NCT01246752. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00915252. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing All
ClinicalTrials.gov study NCT01746147. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01242774. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05183035. IPD Sharing: NO. Countries: 20. Publications: 1.
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
ClinicalTrials.gov study NCT00715637. IPD Sharing: Not stated. Countries: 23. Publications: 2.
A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT01613976. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
ClinicalTrials.gov study NCT03360006. IPD Sharing: NO. Countries: 1. Publications: 2.
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01515527. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
ClinicalTrials.gov study NCT00689000. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04107727. IPD Sharing: NO. Countries: 1. Publications: 1.
Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible
ClinicalTrials.gov study NCT01361334. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for
ClinicalTrials.gov study NCT03298516. IPD Sharing: Not stated. Countries: 2. Publications: 1.
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
ClinicalTrials.gov study NCT03113643. IPD Sharing: NO. Countries: 1. Publications: 2.
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
ClinicalTrials.gov study NCT01556477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.